REGULATE-PCI trial--Author's reply.
Cleveland Clinic Coordinating Center for Clinical Research (C5Research), Cleveland, OH, USA. Electronic address: lincofa@ccf.org.
A Michael
AM
Lincoff
Duke Clinical Research Institute, Duke Medicine, Durham, NC, USA.
John H
JH
Alexander
Mount Sinai School of Medicine, New York, NY, USA.
Roxana
R
Mehran
D000925:Anticoagulants / Q000627:therapeutic use*; D052157:Aptamers, Nucleotide / Q000627:therapeutic use*; D015949:Factor IXa / Q000037:antagonists & inhibitors*; D005260:Female; D006801:Humans; D008297:Male; D010446:Peptide Fragments / Q000627:therapeutic use*; D062645:Percutaneous Coronary Intervention
D000925:Anticoagulants; D052157:Aptamers, Nucleotide; D010446:Peptide Fragments; D015949:Factor IXa